Richard Chambers
- Clinical Psychology top 2%
- Rehabilitation top 2%
-
- Antibiotic Use and Resistance 5
- Transplantation top 5%
-
- HIV/AIDS drug development and treatment 8
- COVID-19 Clinical Research Studies 7
- Antimicrobial Resistance in Staphylococcus 7
-
- Health Systems, Economic Evaluations, Quality of Life 7
-
- Long-Term Effects of COVID-19 6
-
- Bacterial Identification and Susceptibility Testing 6
-
- HIV Research and Treatment 5
- Co-authors
- Nicholas B. AllenEleonora GulloneLucinda L. BakerFernando AntoñanzasSharon K. DeMuthF. William WagnerMandeep R. MehraJennifer Stephens
- Journals
- Journal of Medical Economics (3 papers)BMC Infectious Diseases (3 papers)Value in Health (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Richard Chambers
79 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Clinical Psychology 842
- Experimental and Cognitive Psychology 404
- Rehabilitation 204
- Applied Microbiology and Biotechnology 59
- Transplantation 74
Countries citing papers authored by Richard Chambers
This map shows the geographic impact of Richard Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Chambers more than expected).
Fields of papers citing papers by Richard Chambers
This network shows the impact of papers produced by Richard Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Chambers. The network helps show where Richard Chambers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 32 | |
| 8 | Improving assessment and management of lower limb wounds. | 2019 | 1 |
| 9 | 2019 | 3 | |
| 10 | 2018 | 27 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 47 | |
| 13 | 2013 | 19 | |
| 14 | 2012 | 1 | |
| 15 | 2012 | 4 | |
| 16 | Responding to change | 2010 | 0 |
| 17 | 2001 | 14 | |
| 18 | 2001 | 3 | |
| 19 | The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. | 1997 | 69 |
| 20 | 1997 | 48 |
About Richard Chambers
Richard Chambers is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Transplantation, Virology and Critical Care and Intensive Care Medicine, having authored 84 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), COVID-19 Clinical Research Studies (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Long-Term Effects of COVID-19 (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), HIV Research and Treatment (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Clinical Psychology (842 citations), Experimental and Cognitive Psychology (404 citations), Rehabilitation (204 citations), Applied Microbiology and Biotechnology (59 citations) and Transplantation (74 citations). Richard Chambers has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Nicholas B. Allen, Eleonora Gullone, Lucinda L. Baker, Fernando Antoñanzas, Sharon K. DeMuth, F. William Wagner, Mandeep R. Mehra, Jennifer Stephens, Dwight Stapleton and James Harnett. Their work appears in journals such as Journal of Medical Economics, BMC Infectious Diseases, Value in Health, Clinical Infectious Diseases and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.